Melanoma - A multidisciplinary approach for the general surgeon

被引:11
作者
Reeves, ME [1 ]
Coit, DG [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
关键词
D O I
10.1016/S0039-6109(05)70202-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Surgery continues to be the primary treatment for malignant melanoma. Significant progress has been made in defining appropriate surgical therapy for various stages of the disease. Much of this progress has come from basic science research, which has helped develop active adjuvant therapies and molecular staging approaches. These advances have allowed the surgeon to undertake a multidisciplinary approach to the treatment of melanoma and to provide better outcomes for patients with this disease.
引用
收藏
页码:581 / +
页数:22
相关论文
共 122 条
[71]  
KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654
[72]   Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma [J].
Kunter, U ;
Buer, J ;
Probst, M ;
Duensing, S ;
Dallmann, I ;
Grosse, J ;
Kirchner, H ;
Schluepen, EM ;
Volkenandt, M ;
Ganser, A ;
Atzpodien, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (09) :590-594
[73]   Cancer statistics, 1999 [J].
Landis, SH ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (01) :8-31
[74]   DETECTION OF MINIMAL RESIDUAL CELLS CARRYING THE T(14-18) BY DNA-SEQUENCE AMPLIFICATION [J].
LEE, MS ;
CHANG, KS ;
CABANILLAS, F ;
FREIREICH, EJ ;
TRUJILLO, JM ;
STASS, SA .
SCIENCE, 1987, 237 (4811) :175-178
[75]  
Leong SPL, 1997, ARCH SURG-CHICAGO, V132, P666
[76]   Intraoperative identification of sentinel lymph node in patients with malignant melanoma [J].
Lingam, MK ;
Mackie, RM ;
McKay, AJ .
BRITISH JOURNAL OF CANCER, 1997, 75 (10) :1505-1508
[77]  
Livingston P, 1998, SEMIN ONCOL, V25, P636
[78]   IMPROVED SURVIVAL IN STAGE-III MELANOMA PATIENTS WITH GM2 ANTIBODIES - A RANDOMIZED TRIAL OF ADJUVANT VACCINATION WITH GM2 GANGLIOSIDE [J].
LIVINGSTON, PO ;
WONG, GYC ;
ADLURI, S ;
TAO, Y ;
PADAVAN, M ;
PARENTE, R ;
HANLON, C ;
CALVES, MJ ;
HELLING, F ;
RITTER, G ;
OETTGEN, HF ;
LLOYD, JO .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) :1036-1044
[79]   PHASE-1 TRIAL OF IMMUNOLOGICAL ADJUVANT QS-21 WITH A GM2 GANGLIOSIDE-KEYHOLE LIMPET HEMOCYANIN CONJUGATE VACCINE IN PATIENTS WITH MALIGNANT-MELANOMA [J].
LIVINGSTON, PO ;
ADLURI, S ;
HELLING, F ;
YAO, TJ ;
KENSIL, CR ;
NEWMAN, MJ ;
MARCIANI, D .
VACCINE, 1994, 12 (14) :1275-1280
[80]   APPROACHES TO AUGMENTING THE IMMUNOGENICITY OF MELANOMA GANGLIOSIDES - FROM WHOLE MELANOMA-CELLS TO GANGLIOSIDE-KLH CONJUGATE VACCINES [J].
LIVINGSTON, PO .
IMMUNOLOGICAL REVIEWS, 1995, 145 :147-166